Research Advances Despite Stem Cell Controversy
Professor Henry T. "Hank" Greely is quoted In The Stanford Daily about what impact the "Bush administration's 2001 decision to cut federal funding for the development of new embryonic stem cell lines" had on the Stanford stem cell research program.:
... Prof. Hank Greely said the administration’s move may have actually benefited Stanford research.
“In the long run, without the Bush funding ban, we wouldn’t have the California Institute of Regenerative Medicine which was founded by Prop. 71, and Prop. 71 is pouring more funding into stem cell research than I think we would have gotten from the NIH [National Institutes of Health],” said Greely, who chairs the California Advisory Committee on Human Embryonic Stem Cell Research and the steering committee for the Stanford Center for Biomedical Ethics. “I don’t think we are further behind today than we would have been without Bush’s policy.”
Greely said the political climate for stem cell research funding at the federal level would likely improve with the next presidential administration.
“I do think the temperature on this is likely to be turned down some on January 20, 2009, because whoever becomes president will relax the Bush limits on funding,” he said.
Although Stanford would likely get a share of this increased federal funding, Greely said it would provide a greater benefit to other universities.
“Our peer institutions outside California will benefit more from the increased NIH funding than we will because the California Institute for Regenerative Medicine is pouring more funding into Stanford’s Institute than we will ever get from the NIH,” Greely said.
... and Greely said that as soon as treatment from embryonic stem cells became a reality, protests against the research would stop.